Comparison of small-bowel mucosal injury between low-dose aspirin and non-aspirin non-steroidal anti-inflammatory drugs: A capsule endoscopy study

Digestion

Volumn 89, Issue 3, 2014, Pages 225-231

  Watari, Ikue ^a   Oka, Shiro ^b   Tanaka, Shinji ^b   Igawa, Atsushi ^a   Nakano, Makoto ^a   Aoyama, Taiki ^a   Yoshida, Shigeto ^b   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Capsule endoscopy; Low dose aspirin; Non steroidal anti inflammatory drugs; Small bowel mucosal injury

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; LOXOPROFEN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; POLAPREZINC; REBAMIPIDE; SOFALCONE; TEPRENONE; TROXIPIDE;

ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPE; CAPSULE ENDOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE INJURY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMALL BOWEL MUCOSAL INJURY; SMALL INTESTINE MUCOSA; CLINICAL EVALUATION; COMPARATIVE STUDY; DRUG INDUCED DISEASE; IMAGING SOFTWARE; INJURY SEVERITY; INTESTINE ULCER; MEDICAL RECORD REVIEW; MIDDLE AGED; MUCOSAL DISEASE; REDDENED LESION; RETROSPECTIVE STUDY; SMALL INTESTINE DISEASE; INTESTINE MUCOSA; SMALL INTESTINE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAPSULE ENDOSCOPY; FEMALE; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED;

EID: 84901150870     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000358287     Document Type: Article

References (40)

1. Awtry EH, Loscalzo J: Aspirin. Circulation 2000; 101:1206-1218.
2. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients: BMJ 2002; 324:71-86.
3. Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C: Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353:2373-2383.
4. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M, Wainwright P: Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995; 310: 827-830.
5. Huang JQ, Sridhar S, Hunt RH: Role of Heli-cobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359:14-22.
6. Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, Kuwayama H, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Per-ez-Gutthann S, Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A: Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62:765-772.
7. Singh G, Rosen Ramey D: NSAID-induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998; 51:8-16.
8. Iddan G, Meron G, Glukhovsky A, Swain P: Wireless capsule endoscopy. Nature 2000; 405:417.
9. Fukumoto A, Tanaka S, Shishido T, Takemu-ra Y, Oka S, Chayama K: Comparison of de-tectability of small-bowel lesions between capsule endoscopy and double-balloon en-doscopy for patients with suspected small-bowel disease. Gastrointest Endosc 2009; 69: 857-865.
10. Shishido T, Oka S, Tanaka S, Aoyama T, Wa-tari I, Imagawa H, Yoshida S, Chayama K: Diagnostic yield of capsule endoscopy vs. double-balloon endoscopy for patients who have undergone total enteroscopy with obscure gastrointestinal bleeding. Hepatogastroenter-ology 2012; 59:955-959.
11. Watari I, Oka S, Tanaka S, Nakano M, Aoya-ma T, Yoshida S, Chayama K: Is occult obscure gastrointestinal bleeding a definite indication for capsule endoscopy? A retrospective analysis of diagnostic yield in patients with occult vs. overt bleeding. Gastroenterol Res Pract 2013; 2013:915463.
12. Sugimori S, Watanabe T, Tabuchi M, Kameda N, Machida H, Okazaki H, Tanigawa T, Ya-magami H, Shiba M, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Koike T, Higuchi K, Arakawa T: Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008; 78:208-213.
13. Rácz I: Is low-dose aspirin really harmful to the small bowel? Digestion 2009; 79:42-43.
14. Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Ohya T, Hisatomi K, Teratani T, Ma-tsuhashi N, Nakajima A: Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gas-troenterol 2009; 44:544-549.
15. Graham DY, Opekun AR, Willingham FF, Qureshi WW: Visible small-intestinal muco-sal injury in chronic NSAID users. Clin Gas-troenterol Hepatol 2005; 3:55-59.
16. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3:133-141.
17. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I: A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128:1172-1178.
18. Maiden L, Thjodleifsson B, Seigal A, Bjarna-son II, Scott D, Birgisson S, Bjarnason I: Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenter-ol Hepatol 2007; 5:1040-1045.
19. Matsumoto T, Kudo T, Esaki M, Yano T, Ya-mamoto H, Sakamoto C, Goto H, Nakase H, Tanaka S, Matsui T, Sugano Km Iida M: Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multi-center study. Scand J Gastroenterol 2008; 43: 490-496.
20. Fujimori S, Seo T, Gudis K, Ehara A, Kobaya-shi T, Mitsui K, Yonezawa M, Tanaka S, Ta-tsuguchi A, Sakamoto C: Prevention of non-steroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointest Endosc 2009; 69:1339-1346.
21. Niwa Y, Nakamura M, Miyahara R, Ohmiya N, Watanabe O, Ando T, Kawashima H, Itoh A, Hirooka Y, Goto H: Geranylgeranylace-tone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study. Digestion 2009; 80:260-266.
22. Fujimori S, Gudis K, Takahashi Y, Seo T, Ya-mada Y, Ehara A, Kobayashi T, Mitsui K, Yo-nezawa M, Tanaka S, Tatsuguchi A, Sakamoto C: Distribution of small intestinal mucosal injuries as a result of NSAID administration. Eur J Clin Invest 2010; 40:504-510.
23. Gralnek IM, Defranchis R, Seidman E, Leigh-ton JA, Legnani P, Lewis BS: Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Aliment Pharmacol Ther 2008; 27:146-154.
24. Endo H, Hosono K, Higurashi T, Sakai E, Iida H, Sakamoto Y, Fujita K, Takahashi H, Koide T, Yoneda M, Tokoro C, Inamori M, Abe Y, Matsuhashi N, Nakajima A: Quantitative analysis of low-dose aspirin-associated small bowel injury using a capsule endoscopy scoring index. Dig Endosc 2011; 23:56-61.
25. Higuchi K, Umegaki E, Watanabe T, Yoda Y, Morita E, Murano M, Tokioka S, Arakawa T: Present status and strategy of NSAID-in-duced small bowel injury. J Gastroenterol 2009; 44:879-888.
26. Fujimori S, Takahashi Y, Gudis K, Seo T, Eha-ra A, Kobayashi T, Misui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C: Re-bamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy. J Gas-troenterol 2011; 46:57-64.
27. Niwa Y, Nakamura M, Ohmiya N, Maeda O, Ando T. Itoh A, Hirooka Y, Goto H: Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gas-troenterol 2008; 43:270-276.
28. Shiotani A, Haruma K, Nishi R, Fujita M, Ka-mada T, Honda K, Kusunoki H, Hata J, Graham DY: Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 2010; 45:292-298.
29. Smecuol E, Pinto Sanchez MI, Suarez A, Ar-gonz JE, Sugai E, Vazquez H, Litwin N, Piazu-elo E, Meddings JB, Bai JC, Lanas A: Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009; 7: 524-529.
30. Endo H, Hosono K, Inamori M, Kato S, No-zaki Y, Yoneda K, Akiyama T, Fujita K, Taka-hashi H, Yoneda M, Abe Y, Kirikoshi H, Ko-bayashi N, Kubota K, Saito S, Matsuhashi N, Nakajima A: Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009; 79:44-51.
31. Endo H, Higurashi T, Hosono K, Sakai E, Sekino Y, Iida H, Sakamoto Y, Koide T, Taka-hashi H, Yoneda M, Tokoro C, Inamori M, Abe Y, Nakajima A: Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. J Gastroenterol 2011; 46:894-905.
32. Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T: Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008; 6:1279-1282.
33. Bajarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ: Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27:1292-1297.
34. Somasundaram S, Rafi S, Hayllar J, Sigthors-son G, Jacoc M, Parice AB, Macpherson A, Mahmod T, Scott D, Wrigglesworth JM, Ba-jarnason I: Mitochondorial damage: a possible mechanism of the 'topical' phase of NSAID-induced injury to the rat intestine. Gut 1997; 41:344-353
35. Takeuchi K, Hase S, Mizoguchi H, Komoike Y, Tanaka A: Protection by aspirin of indo-methacin-induced small intestinal damage in rats: mediation by salicylic acid. Paris 2001; 95:51-57.
36. Watari I, Oka S, Tanaka S, Aoyama T, Imaga-wa H, Shishido T, Yoshida S, Chayama K: Effectiveness of polaprezinc for low-dose aspirin-induced small-bowel mucosal injuries as evaluated by capsule endoscopy: a pilot randomized controlled study. BMC Gastroenter-ol 2013; 13:108.
37. Imaeda H, Fujimoto T, Takahashi K, Kasumi E, Fujiyama Y, Andoh A: Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut micro-biota profiles of indomethacin-and rebamip-ide-treated mice. Digestion 2012; 86:250-257.
38. Lim YJ, Phan TM, Dial EJ, Graham DY, Lich-tenberger LM: In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phos-phatidylcholine. Digestion 2012; 86:171-177.
39. Lanas A, Scarpignato C: Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? Digestion 2006; 73:136-150.
40. Fujimori S, Takahashi Y, Seo T, Gudis K, Eha-ra A, Kobayashi T, Mitsui K, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C: Prevention of traditional NSAID-induced small intestinal injury: recent preliminary studies using capsule endoscopy. Digestion 2010; 82: 167-172.